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Background: Cognitive and motor task performance in premanifest Huntington's disease (HD) gene-carriers is
often within normal ranges prior to clinical diagnosis, despite loss of brain volume in regions involved in these
tasks. This indicates ongoing compensation, with the brain maintaining function in the presence of neuronal
loss. However, thus far, compensatory processes in HD have not been modeled explicitly. Using a new model,
which incorporates individual variability related to structural change and behavior, we sought to identify func-
tional correlates of compensation in premanifest-HD gene-carriers.
Methods:We investigated the modulatory effects of regional brain atrophy, indexed by structural measures of
disease load, on the relationship between performance and brain activity (or connectivity) using task-based
and resting-state functional MRI.
Findings: Consistent with compensation, as atrophy increased performance-related activity increased in the right
parietal cortex during a workingmemory task. Similarly, increased functional coupling between the right dorso-
lateral prefrontal cortex and a left hemisphere network in the resting-state predicted better cognitive perfor-
mance as atrophy increased. Such patterns were not detectable for the left hemisphere or for motor tasks.
Interpretation:Our ﬁndings provide evidence for active compensatory processes in premanifest-HD for cognitive
demands and suggest a higher vulnerability of the left hemisphere to the effects of regional atrophy.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).roscience, University College London, 17 Queen Square, London WC1N 3AR, UK.
egenerative Disease, UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, Queen Square, London
prion.ucl.ac.uk (S.J. Tabrizi).
. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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In neurodegenerative disease, progressive degenerative changes can
be detected many years prior to the manifestation of clinical symptoms
including cognitive and motor deﬁcits. Such ﬁndings indicate that the
brain has capacity to compensate for degenerative losses, maintaining
normal levels of cognitive and motor function, until such time that
neuropathology translates into clinical loss of function. For example, in
Huntington's disease (HD), a fully penetrant monogenic disorder, indi-
viduals far from the onset of overt signs and symptoms demonstrate
extensive neuroimaging evidence of subcortical and cortical atrophy.
However, such HD expansion mutation carriers perform similarly
to healthy controls on a wide variety of motor and cognitive tests and
show minimal longitudinal change in performance (Tabrizi et al.,
2011; Papoutsi et al., 2014).
We can postulate two differentmechanisms that might be responsi-
ble for this dissociation between progressive structural pathology and
minimal measurable phenotypical behavioral change. Inherent cog-
nitive reserve may mitigate against the emergence of measurable
phenotypical alterations before a threshold for functional degradation
is exceeded. Alternatively, secondary compensatory mechanisms, in
which brain pathology leads to adaptation of neural activity patterns,
may emerge in the course of the disease process and could create alter-
native or modiﬁed neural processes to support maintenance of cogni-
tive and motor function at normal levels. However, no universally
accepted deﬁnition of compensation exists (Barulli and Stern, 2013),
and the underlying mechanisms are unknown.
Our previous longitudinal multi-site study (Track-HD) showed
disease-related reductions in striatal and white matter volume (Tabrizi
et al., 2009), and elevated rates of atrophy from the very earliest
premanifest stages (Tabrizi et al., 2011, 2012, 2013). Despite this
consistent progressive structural loss, high levels of functional per-
formance are maintained in this cohort and there is little evidence
of cognitive or motor decline over time (Tabrizi et al., 2009, 2011,
2012, 2013). The current study (Track-On HD) was designed to ex-
plore the hypothesis that compensatory brain networks exist to
maintain function in the presence of widespread structural damage
during the premanifest phase of HD.
Recent functional neuroimaging studies indicate augmented task-
related brain activity in premanifest HD expansion mutation-carriers
compared with healthy control or manifest HD groups, (Georgiou-
Karistianis et al., 2013; Gray et al., 2013; Klöppel et al., 2009; Novak
et al., 2012; Poudel et al., 2013; Scheller et al., 2013; Wolf et al., 2007;
Malejko et al., 2014) providing evidence of increased subcortical
(Georgiou-Karistianis et al., 2013; Malejko et al., 2014), and cortical ac-
tivation in both prefrontal and parietal cortex as well as supplementary
motor areas (Klöppel et al., 2009; Scheller et al., 2013). Typically,
published studies using such comparisons neither take into account
disease-related structural alterations within the groups, nor the vari-
ability in performance within each group. Moreover, using group com-
parison leaves open the possibility that the observed differences in
brain activity are not task-related but instead reﬂect a superimposed ef-
fect of neurodegenerative pathology. To overcome these challenges, we
developed a measure of neural compensation that takes into account
the relationships between behavioral performance and brain activity
(or connectivity) seen in healthy individuals, and applied it to functional
MRI (fMRI) measures of brain activity in a large cohort of over 100 indi-
viduals with premanifest-HD (preHD). We hypothesized that neural
compensation could be identiﬁed as a positive change in the relation-
ship between performance and brain activation in association with rel-
atively high levels of structural alterations reﬂecting the impact of the
disease processes (‘structural disease load’). Speciﬁcally, we hypo-
thesized that for those brain regions showing compensation, higher
structural disease load would be associated with tighter relationships
between performance and brain activity (Fig. 1 and Eq. (1), Materials
and Methods) indicating a need for greater task-associated neuralactivity to maintain similar levels of performance in individuals with
higher structural disease load.
We characterized structural disease load using volumetric measures
of the caudate, putamen, global gray and global white matter that show
sensitivity towards HD-related changes (Tabrizi et al., 2012). These
structural markers of disease load were included in a systematic exam-
ination of both brain activity and connectivity. Brain activity was mea-
sured during performance of a motor or cognitive task using task-fMRI
and brain connectivity within cognitive and motor networks using
resting-state fMRI (rsfMRI). This allowed us to perform a comprehen-
sive, unbiasedwhole-brain assessment of potentialmarkers of compen-
sation for neurodegeneration in preHD.
2. Materials and Methods
2.1. Participants
239 participants were recruited from the four Track-On HD study
sites and comprised the following three groups: (1) 106 individuals
without HD but carrying the mutant huntingtin gene (F 54; mean
age ± SD: 42 · 80 ± 9 · 10), (2) 22 early HD patients (F 15, mean
age± SD: 45 · 22±7 · 89), and (3) 111 age- and sex-matched controls
(F 67,mean age±SD: 48 · 14±10 · 70). The 22 early HDpatientswere
removed from all analyses as very few participated in all assessments.
14 participants were left-handed and were excluded from the motor
fMRI task and resting state analyses (Oldﬁeld, 1971). Most preHD and
control participants were recruited from the Track-HD study (Tabrizi
et al., 2009). Newly-recruited preHD participants were required to
have a CAG repeat length ≥40 and a disease burden score greater than
250 at recruitment (Penney et al., 1997). Newly recruited control partic-
ipants were either the partner or spouse of a participant, not at risk
of HD, or HD normal-repeat-length sibling or control volunteers. For
both groups, exclusion criteria included manifest disease, age below
18 or above 65 (unless previously in Track-HD study),major psychiatric,
neurological or medical disorder or a history of severe head injury (see
Supplementary Data). The study was approved by the local ethics com-
mittees and all participants gave written informed consent according to
the Declaration of Helsinki.
2.2. Power Calculation
The current Track-On study was meant as an exploratory extension
of the highly successful Track-HD study. The main purpose was to gen-
erate high resolution structural and fMRI data to explore issues such as
compensation. Because such data were not previously generated from
Track-HD, and compensation was not examined, there was no princi-
pled means of estimating required sample size. Now that these data
have been collected and analyzed, sample size calculation is possible
for future studies.
2.3. Behavioral Measures
A principal component analysis was performed on nine cognitive
assessments to derive a global cognitive composite score (see
Supplementary Data). Based on the Track-HD study (Tabrizi et al.,
2013), the Uniﬁed Huntington's Disease Rating Scale (UHDRS)–
Total Motor Score (TMS), and Grip Force Variability (GFV) were selected
as markers of motor performance in both the task and rsfMRI analyses
as both are sensitive to HD-related change (see Supplementary Data)
Reilmann et al. (2010) and Group (1996).
2.4. fMRI Tasks
2.4.1. Verbal Working Memory (VWM) Task
Participants performed a VWM n-back task with two levels of
working memory load (1-back and 2-back) (Fig. 2). During the
Fig. 1. Example conditioning plot with simulated data. The upper panel depicts the overlapping ranges of structural disease load as measured by brain volume (the slabs) that determine
the subsample for each scatterplot panel below. Observed points are plotted in the lower panel scatterplots for each range of brain volume, and a linear regression line is ﬁt separately in
each panel to aid interpretation. The structural disease load (brain volume) range determines what subsample is selected from the data set for the scatterplot of task performance as a
function of fMRI signal, with the color coding showing the correspondence. For example, the extreme left scatterplot (red) includes the smallest brain volume (highest disease load)
range from the data set (lower left red slab). The extreme right scatterplot (blue) includes the largest volume (lowest disease load) range from the data set (upper right blue slab). Of
note, regression lines and the separation in different slabs have illustrative purposes only and are not the basis of the underlying statistic.
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quired to respond according to whether the letter on screen was
the same as the letter presented one letter previously (1-back) or
presented two letters previously (2-back) using a button box. A
third condition (0-back) whereby participants indicated whether
the letter A or B was presented on screen served as a baseline mea-
sure (see Supplementary Data). Performance in the 1-back and 2-
back conditions was analyzed using both the d-prime coefﬁcient
(probability of correct response minus probability of false positive
responses) and reaction times and assessed across groups and con-
ditions using a repeated measures ANOVA adjusting for age, gender,
site and education.
2.4.2. Sequential Finger Movement (SFM) Task
Participants performed a motor task that involved metronome-
paced ﬁnger tapping with their right (dominant) hand (see Klöppel
et al., 2009 for a detailed description; Fig. 2). Speed and complexity of
the tapping sequence were varied to test executive (speed) and cog-
nitive (complexity) demands of the task (see Supplementary Data).
Mean timing inaccuracies (cue-response intervals) and standard devia-
tionswere analyzed using a 2 × 2 × 2 repeatedmeasures ANCOVA, with
complexity (simple or complex) and speed (slow or fast) as within-
subject factors and group as a between-subject factor, adjusting for
age, gender, site and education.
2.5. MRI Data Acquisition
3T MRI data was acquired on two different scanner systems (Philips
Achieva at Leiden and Vancouver and Siemens TIM Trio at London and
Paris), as described (Tabrizi et al., 2009). For task and rsfMRI, whole-
brain volumes were acquired at a repetition time of 3 s using a T2*-
weighted echo planar imaging (EPI) sequence with the following pa-
rameters: TE 30 ms, FOV 212 mm, ﬂip angle 80°, 48 slices in ascending
order (slice thickness: 2 · 8 mm, gap: 1 · 5 mm, in plane resolution
3 · 3 × 3mm) and bandwidth of 1906 Hz per Px. Rs-fMRI data were col-
lected ﬁrst, then both sets of task fMRI data. For rs-fMRI, 165 volumes
were acquired over 8:20min followed byﬁeldmap acquisition. 225 vol-
umes over 11:15 min for the SFM task and 190 volumes over 9:30 minof VWMtask fMRI data. Fieldmapswere acquiredwith TR 1020ms, TE1
10 · 0 ms, TE2 12 · 46 ms, FOV 212 mm and 2 mm slice thickness. All
data were visually inspected by IXICO. Standardisation of data acquisi-
tion across sites was performed based on previous suggestions (see
Supplementary Data) (Glover et al., 2012).
2.6. MRI Data Processing
T1-weighted images were processed as described (Tabrizi et al.,
2009). Regional volumes were adjusted for intracranial volume (ICV)
and used as structural disease load measures for compensation analy-
ses. fMRI data preprocessing and subsequent statistical analyses were
performed using SPM8 running under MATLAB. The T1 scan was seg-
mented into gray and white matter using the VBM8 toolbox (http://
dbm.neuro.uni-jena.de/vbm/) and used to create an improved anatom-
ical scan for coregistration. Using the DARTEL extension, deformation
parameters were extracted for normalization of functional images
(Ashburner, 2007). The ﬁrst four EPI images were discarded to allow
for steady state equilibrium. Functional images were ﬁrst realigned
and ﬁeld maps used for inhomogeneity correction whenever available.
For rsfMRI, all EPI imageswere then coregistered to the new anatomical
image and normalized using DARTEL deformation parameters. For
task fMRI, only contrast images were normalized. Finally, data were
smoothed using a 6mmfullwidth at halfmaximumGaussian kernel. Al-
though for task fMRI a smoothing kernel of 8mm ismore conventional, in
the current study we used a kernel of 6 mm for consistency between
rsfMRI and task fMRI data (for Quality Control see Supplementary Data).
2.7. MRI Data Analysis
2.7.1. Task fMRI Data Speciﬁc Analyses
A ﬁrst-level analysis based on the general linear model (GLM) was
performed for each participant on the smoothed images. Task-related
BOLD signal changes were estimated for each task condition. Six move-
ment regressors were also modeled, in addition to the instruction screen,
single button presses during rest and blocks during which participants
performed a wrong condition for the motor task (for Group Analysis see
Supplementary Data). The 2-back vs 1-back contrast (VWM) and
Fig. 2. Task fMRI paradigms. Example trials for a) the verbal working memory n-back task and b) sequential ﬁnger tapping. Please see Materials and Methods for further details.
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were used to identify the signiﬁcant voxels (p b 0.05 FWE-corrected)
which entered the whole brain compensation analyses described below.
In the compensation model, ﬁndings are reported at p b 0 · 001 without
correction for multiple comparisons.
2.7.2. Resting State fMRI Analysis
Resting state fMRI data is used to interrogate task-positive net-
works including, among others, motor, attention and executive
function networks, in the brain at rest Beckmann et al. (2005) and
Smith et al. (2012). Resting state fMRI data were analyzed using
two complementary connectivity analysis techniques. Seed-region
based correlation (functional connectivity) was used to investigate
temporal correlations between activity within a region speciﬁc to a
network of interest and the whole brain. Dynamic Causal Modeling
(DCM; effective connectivity) probed causal inﬂuence between a
number of network-relevant regions within a pre-deﬁned model
(Li et al., 2011).
2.7.2.1. Functional Connectivity Analyses. Seed regions of interest for the
cognitive network were located in the left and right Dorsolateral Pre-
frontal Cortex (DLPFC) (Owen et al., 2005), and for the motor network
within the left primary motor cortex (M1). The time series for each
seed region was extracted from the smoothed scans using a 4mm radiussphere, centered on the seed region co-ordinates (see Supplementary
Data). The extracted time-series was then entered into a GLM which
also included the representative non-neuronal time-series for both
white matter and CSF signal (extracted as above) and six movement re-
gressors. The individual correlation maps for each seed region analysis
were included in a one-tailed, one sample t-test of all participants. Param-
eter estimateswere extracted fromvoxel clusterswith signiﬁcant positive
correlations (p b 0 · 05 FWE-corrected) using the SPM toolbox MARSbar
v0 · 43 (http://marsbar.sourceforge.net/) and entered our compensation
model.
2.7.2.2. Effective Connectivity Analyses. Regions for the network models
were derived from the task-fMRI analyses (Fig. 3) and all biologically
plausible connections modeled (see Supplementary Data). The time-
series for each region was extracted from all voxels within an 8 mm
radius sphere centered on the co-ordinates using a GLM that included
whitematter and CSF signal in addition tomovement regressors. Cogni-
tive and motor networks were then modeled using DCM speciﬁcation
and estimation carried out with DCM10 in Statistical Parametric Map-
ping software (SPM12b; Wellcome Trust Centre for Neuroimaging,
http://www.ﬁl.ion.ucl.ac.uk/spm). Resultant effective connectivity
parameters were entered into a one-sample t-test of all participants
and signiﬁcant connectivity values (FDR-corrected) extracted and ex-
amined within our compensation model.
Fig. 3. Dynamic causal models employed for resting state fMRI. a) Motor network and
b) cognitive network. Abbreviations: ACC: anterior cingulate cortex; DLPFC: dorsolateral
prefrontal cortex; PMC: premotor cortex; PPC: posterior parietal cortex; and SMA: supple-
mentary motor area.
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Fig. 1 is a conditioning plot that illustrates the basic concept of com-
pensation. The crux of compensation is that the relationship between a
response variable (cognitive or motor) and an fMRI variable is condi-
tional on (or varies by) structural disease load (brain volume). Underly-
ing this concept is the statistical interaction among structural disease
load and the fMRI variable in question. The compensation model was
deﬁned as the following. Suppose a performance measure is denoted
as y, structural disease load is denoted as d, fMRI-signal is f, and a vector
of covariates is c. Then the statistical model can be written as
y ¼ α þ β1dþ β2 f þ β3 dð Þ fð Þ þ γc þ e ð1Þ
whereα is the intercept or offset, theβ1 andβ2 aremain effects,β3 is the
interaction termbetween structural disease load and fMRI activity,γ is a
vector of regression coefﬁcients for the covariates, and e is randomerror
(assumed to be normally distributed with zeromean and non-zero var-
iance). Evidence for compensation was provided by the rejection of the
null hypothesis,H0 : β3= 0, whichmeant that the relationship between
f and y varied signiﬁcantly by d (cf. Fig. 1). Structural disease load was
represented by caudate, putamen, white matter or gray matter volume
as a fraction of total intracranial volume. These volumes were analyzed
one at a time. To control for potential confounding effects, γc adjusted
for age, gender, study site, education level, and cumulative probability
of onset (CPO), the latter being included to account for current disease
status. fMRI-signal either represented task-speciﬁc activations or func-
tional or effective connectivity for the rsfMRI analyses.
Visualization of interactions was accomplished using conditioning
plots (Fig. 1). The coplot consists of two types of panels. The upper
panel consists of slabs that show the overlapping ranges of the structural
disease load conditioning variable that dictates which observations from
the sample are selected for illustration. The intervals of the conditioning
structural disease load variable have the properties that approximately
the same number of observations lies in each interval and approximately
the same number of observations lies in two successive intervals
(Chambers, 1992). The lower panels show the scatterplot of the selected
observations for the performance variable (vertical axis) and the fMRI
variable (horizontal axis). For illustrative (and not inferential) purposes,
a linear regression line is ﬁt to each scatterplot separately. The interior
scatterplot panels illustrate the changing relationship between perfor-
mance and fMRI activation over part of the range of the structural disease
load variable.
For task fMRI data, the compensationmodelwas applied to all voxels
individually within the respective task-speciﬁc main effect. For the
rsfMRI-based connectivity analyses, the compensation model was ap-
plied to the average signal value extracted from each regionsigniﬁcantly correlated with seed regions and each signiﬁcant connec-
tion from the respective cognitive and motor network DCM. As predict-
ed markers of performance, for task fMRI, we used behavioral data
obtained while performing the VWM and SFM tasks in the scanner.
For rsfMRI data the global cognitive composite score, GFV and UHDRS-
TMS were used.
Alpha-adjustment was not used in the multiple tests of H0 : β3 = 0
for the following reasons. Neuroscience meta-analysis indicates that ef-
fects in the ﬁeld tend to be small and the statistical power tends to be
low in general (Button et al., 2013; Uttal, 2013). Compensation effects
are expected to be especially small because they are expressed in an in-
teraction term among correlated predictors, as shown in Eq. (1). The
compensation interaction must show an effect over and above the
main effects with which it is correlated, perhaps highly so. Given the
compensation deﬁnition of Eq. (1) and the fact that the study was not
powered to detect compensation, the decision was made to use the
nominal p ≤0 · 05 criterion for statistical signiﬁcance for all compensation
tests. The justiﬁcation was the ability to detect relatively fragile
compensation effects that would probably never endure alpha-
adjustment with such a small sample size. The lack of adjustment
does provoke strong caution regarding the interpretation of the results.
p-Values close to 0 · 05might require very large sample sizes for replica-
tion and can have spuriously inﬂated effect sizes (Colquhoun, 2014).
3. Results
3.1. Cognitive Network
3.1.1. VWM Task fMRI
For behavioral and main effect fMRI analyses see Supplementary
Data. We performed whole brain compensation analyses separately
for each voxel signiﬁcant for the main effect of VWM (p b 0 · 05,
corrected). The compensation interaction was statistically signiﬁcant
for the right superior parietal cortex (x = 39, y =−60, z = 45; T =
3 · 47, p b 0 · 002) and the inferior parietal cortex (x = 38, y =−54,
z = 29; T = 4 · 18, p b 0 · 001). This relationship between VWM-task
performance and the parietal cortex activity conditional on structural
disease load (caudate volume) is visualized in Fig. 4. There was a rela-
tively strong and positive relationship between VWM-task performance
and cortex activity for high structural disease load, but the relationship
diminished as structural disease load lightened with the lowest struc-
tural disease load showing no relationship. Similar results were also ev-
ident when using putaminal volume, but not white or gray matter as
markers of structural disease load.
3.1.2. Resting State fMRI — Functional Connectivity and Compensation
For the right DLPFC seed, this analysis revealed that functional con-
nectivity between the right DLPFC and a distributed set of regions in
the left hemisphere (Figs. 5 and 6; Fig. S3; Table S3) exhibited a statisti-
cally signiﬁcant interaction between coupling and disease load in the
prediction of global cognitive performance. As seen in Fig. 6, the rela-
tionship between coupling and global cognitive performance increased
as structural disease load increased, consistentwith our operational def-
inition of compensation, but decreased in those furthest from onset
(with the lowest structural disease load). The regions whose coupling
with right DLPFC showed such a relationship included the fusiform
gyrus (FFG) (p = 0 · 010), the inferior frontal gyrus (p = 0 · 019),
the hippocampus (p = 0 · 034), the superior temporal gyrus (p =
0 · 049), and the anterior cingulate cortex (ACC) (p= 0 · 051); howev-
er, only the FFG survived the pre-planned Bonferroni-correction for
structural disease load. The ﬁrst three ﬁndings were observed using
gray matter volume as the measure of structural disease load, and the
latter two using putamen volume. In all these regions, the correlations
between global cognitive performance and functional connectivity
that demonstrated increased slope with structural disease load suggest
a compensatory effect in the right hemisphere in preHD.
Fig. 4.D-Prime performance as a function of fMRI task activationwithin the parietal cortex, conditional on caudate volume as ameasure of structural disease load. For each plot, the upper
panel depicts the overlapping ranges of caudate volume that determinewhich subsample is selected from the data set that is used to construct each scatterplot. A linear regression linewas
ﬁt for each scatterplot to aid interpretation.
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between the left DLPFC and a number of regions that was associated
with global cognitive performance had a negative relationship thatFig. 5. Overview of functional connectivity analyses for the cognitive network. Regions
that signiﬁcantly correlated (p b 0.05 FWE-corrected) with seed regions in the right
(blue) or left DLPFC (green) and which also, as part of the compensation model, signiﬁ-
cantly predicted global cognitive performance as structural disease load increased. Abbre-
viations: ACC: anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; FFG:
fusiform gyrus; HC: hippocampus; IPC: inferior parietal cortex; and SMG: supramarginal
gyrus. STG: superior temporal gyrus.varied by structural disease load (Figs. 5 and 7; Table S4). These regions
included the left inferior parietal cortex (p = 0 · 007), ACC (p =
0 · 004) and the left supramarginal gyrus (SMG) (p = 0 · 003), all of
which survived Bonferroni-correction for structural disease load, in ad-
dition to correlations with the left putamen (p= 0 · 01) and right SMG
(p= 0 · 042), which did not survive Bonferroni-correction. All correla-
tionswere observed using graymatter volume as ameasure of structur-
al disease load; with the inferior parietal cortex also signiﬁcant when
usingwhitematter as amarker of structural disease load. In all these re-
gions, we therefore found relationships between resting-state brain ac-
tivity, structural disease load and global cognitive performance that,
according to our deﬁnition of compensation, argue against compensato-
ry effects being evident in the left hemisphere for preHD.
3.1.3. Resting State fMRI — Effective Connectivity and Compensation
We did not ﬁnd any DCM connectivity parameters that were cor-
related with global cognitive performance and changed with disease
load in a fashion predicted by our compensation hypothesis (see
Supplementary Data).
3.2. Motor Network
3.2.1. SFM Task fMRI
For behavioral and main effect analyses see Supplementary Data.
The compensation model did not reveal any signiﬁcant relationship be-
tween speed and complexity (as performance markers), brain activity
and structural disease load. This remained the case even when using
an exploratory threshold of p b 0 · 01 uncorrected.
3.2.2. Resting State fMRI — Functional Connectivity and Compensation
In the ﬁrst step of this analysis, we did not ﬁnd any regions in which
activity signiﬁcantly (p b 0 · 05, corrected) correlated with that of the
left M1. Therefore, no further compensatory analyses of functional con-
nectivity for the motor network were conducted.
3.2.3. Resting State fMRI — Effective Connectivity and Compensation
Findings are indicative of a non-compensatory effect in both hemi-
spheres in those preHD close to onset (see Supplementary Data).
Fig. 6. Global cognitive performance as a function of rsfMRI functional connectivity between right DLPFC and left hippocampus, conditional on gray matter volume as a measure of
structural disease load. For each plot, the upper panel depicts the overlapping ranges of gray matter volume that determine which subsample is selected from the data set that is used
to construct each scatterplot. A linear regression line was ﬁt for each scatterplot to aid interpretation.
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Weused a newapproach to investigate and characterize at a systems
level neural compensation in preHD, by characterizing the relationship
between brain activity and task performance, conditional on structural
disease load. We combined task and rsfMRI with structural MRI-
derived volumetric measures of disease load, and detailed clinical, cog-
nitive, and motor assessment, and identiﬁed a potential compensatory
network in which increases in right-hemisphere activation and connec-
tivity predicted better preserved cognitive performance in HD expan-
sion mutation-carriers with higher structural disease load.
Investigation of speciﬁc regions associated with performing a VWM
task and modulated by task difﬁculty revealed progressively more
positive correlations between activity in a region of the right parietal
cortex and better detection accuracy during the VWM task in those ap-
proaching disease onset (compared to those further from disease
onset). Complementing these ﬁndings, a simple seed-based functional
connectivity approach using resting state data identiﬁed a network of
compensatory connections focused in the right hemisphere. These pat-
terns of connectivity in the resting state demonstrate a relationship be-
tween task performance and activity that changedwith disease load in a
manner consistent with our operational deﬁnition of compensation.
In contrast, brain activity and connectivity centered in the left hemi-
sphere showed no evidence of compensatory changes in activity. A
functionally more resilient right hemisphere is consistent with ﬁndings
from previous studies (Lambrecq et al., 2013; Muhlau et al., 2007),
which have already indicated that HD-pathology is in a subtle, but ro-
bust fashion, leftward biased. Use and stress-related neuronal demands,
potentially including excitotoxic mechanisms, may be more pro-
nounced in the dominant left hemisphere andmay underlie asymmetry
(Jenkins et al., 1998). The notion of a subtle but reproducible larger left-
hemispheric deterioration in HD requires further investigation in terms
of the pathophysiological underpinnings of this asymmetry. For exam-
ple, these changes could be related to a more metabolically active left
hemisphere with higher energy demands (Mochel et al., 2012), thus
making it more susceptible in HD, in which bioenergetic defects are
well documented (Ross and Tabrizi, 2011). Alternatively, it may reﬂecta use-dependent possible prion-like spread of mutant huntingtin
resulting in more subtle, but extensive damage in the left hemisphere
in a functional connectivity-dependent fashion (Ross et al., 2014).
It is surprising that despite evidence of compensation in cognitive
networks associated with working memory performance, neither the
task-based nor the rsfMRI-based effective connectivity analyses provid-
ed evidence of a compensatory mechanism in the motor system. For
task-based fMRI, this could potentially be due to the use of a motor
task that was insufﬁciently challenging to participants to engage com-
pensatory processes. Of note, a SFM task previously studied in preHD
with more demanding difﬁculty levels than those used in the current
study revealed some evidence of compensation Klöppel et al. (2009).
In this study, participants were required to memorize an irregular 10-
item sequence of ﬁnger movements. Here, we aimed to remove the
working memory component from the SFM task and replace it with
an independent working memory task. Importantly the compensation
model used in the previous study did not consider differing levels of
performance within preHD and healthy participants, as did the current
compensation model. Differences between the studies could therefore
relate to the precise compensationmodel used, emphasizing the impor-
tance of operationally and explicitly deﬁning neural compensation. Our
rsfMRI-based analysis of functional coupling between key regions of the
motor system did not provide any additional insights, as no regions
were sufﬁciently correlated with the seed region to enter compen-
sation analyses. Based on previous evidence, we did expect to see
correlations between activity within the M1 and that of other re-
gions of the brain, particularly regions within the motor network.
We did identify signiﬁcant correlations, but these were present at
lower thresholds. Given that our thresholds were deﬁned a priori
and that the connectivity parameters were simply extracted for
inclusion in our compensation model, we were unable to report
lower threshold ﬁndings. For future longitudinal analyses, we will
modify our approach to include regions of the motor network that
are temporally correlated.
DCM-based markers of effective connectivity between pre-speciﬁed
regions of the motor network also did not indicate any compensation.
However, it should be noted that DCM is limited by the necessity to
Fig. 7.Global cognitive performance as a function of rsfMRI functional connectivity between leftDLPFC and a) anterior cingulate cortex, or b) left inferior parietal cortex, conditional ongray
matter volume as a measure of structural disease load. For each plot, the upper panel depicts the overlapping ranges of gray matter volume that determine which subsample is selected
from the data set that is used to construct each scatterplot. A linear regression line was ﬁt for each scatterplot to aid interpretation.
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volving brain areas not incorporated in the pre-deﬁned list of regions
of interest would remain undetected. In addition, a compensatory
mechanism may become apparent only at a time window very close
to the emergence of phenotypical motor abnormalities or may not be
operative at all for the motor system. This is consistent with a concept
of basal ganglia function that postulates a basic, fundamental role in
movement sequencing and postural adjustments in anticipation of voli-
tional movements that can neither be replaced nor compensated for
once damaged beyond a certain threshold, thus resulting in increasingly
degraded motor performance as the degenerative processes progress.We investigated four different (anatomical) markers of structural
disease load and their relationship with brain activity and task perfor-
mance. Whole brain gray matter as a percentage of total intracranial
volume was themarker of structural disease loadmost often associated
with compensation-like changes in these relationships in the rsfMRI
analyses. In previous analyses involving many of the same participants,
gray matter degeneration accelerates close to disease onset (Tabrizi
et al., 2013). However, for both task activation and resting state analy-
ses, signiﬁcant compensatory and non-compensatory effects were ob-
served using all four measures of structural disease load. In this study,
we treated each measure of disease load as statistically independent.
1428 S. Klöppel et al. / EBioMedicine 2 (2015) 1420–1429Given that the striatum, graymatter andwhitematter all degenerate, al-
beit at different rates, during the premanifest stage of HD, they are likely
statistically dependent. For future studies, it may prove more useful to
integrate all four measures within a multivariate analysis to account
for the relationships between the individual measures.
Our deﬁnition of compensation was in part derived from the com-
pensation criteria detailed in Cabeza and Dennis Cabeza and Dennis
(2013); in particular, that for successful compensation to be present,
an increase in activation should be positively associated with an in-
crease in task performance (positive relationship). However, it is possi-
ble that there are alternative deﬁnitions and underlyingmechanisms of
compensation that may also be appropriate for future investigation,
which are not consistent with our operational deﬁnition. For example,
compensatory processes may be driven by the downregulation of path-
ologically high signals or the potential disengagement of brain regions.
These mechanisms would be reﬂected within our model as negative
correlations between brain activity (within certain regions) and perfor-
mance conditional on structural disease load. Furthermore, the current
study highlights compensatory activity in regions such as the FFG and
the hippocampus which are not routinely associated with general cog-
nitive processing it is this potential recruitment of alternative pathways
that we will look to investigate further in future studies with longitudi-
nal data, in addition to the negative correlations and the changes in
these associations over time.
We recognize that our study has a number of limitations. Despite a
large sample size and our a priori deﬁnition of a compensation model,
we found comparatively little evidence for widespread neural compen-
sation in our presymptomatic HD gene carriers. This may reﬂect a true
negative ﬁnding that there is little underlying compensation in the pre-
symptomatic phase of neurodegeneration occurring during the states
we chose for fMRI measurement. The tasks we examined (working
memory and motor tasks) showed no large difference in behavior be-
tween healthy and premanifest HD groups. Such ﬁndings are consistent
with neural compensation, but are of course also consistent with the
possibility that compensation in those particular tasks does not play a
large role. Alternatively, it may be a false negative ﬁnding; that despite
our large sample size, statistical power may be inadequate to detect
compensation. In particular, our operational deﬁnition of compensation
hypothesizes an interaction between different measures in the context
of the linear statistical models employed here. Power to detect such
interactions is inherently much lower than that required to detect so-
calledmain effects of individual variables.We have argued that such in-
teractions are a necessary, but previously overlooked aspect of the def-
inition of disease compensation. Future work will be able to explicitly
investigate whether the compensation effects identiﬁed here replicate
in the same or different cohorts; and investigate whether a single
weighted measure of structural disease load across the brain may be
more appropriate than the four measures (necessitating correction for
multiple comparisons) used here.
This study has highlighted the complexity of operationally deﬁning
compensation in neurodegenerative diseases such as HD. The previous
literature in HD has thus far failed to address this issue, instead making
assumptions of putative compensation based solely on increased activa-
tion or connectivity in high disease load groups compared to those with
lower levels of disease or healthy controls and typically did not include
performance level (Scheller et al., 2014). We cannot therefore differen-
tiate between functional changes that are due to HD pathology and
those that represent compensatory behavior. Here, we explicitly
modeled the interaction between fMRI signals and structural disease
load as a predictor of cognitive and motor performances taking into ac-
count both variability in structural disease load and performance. By ex-
plicitly considering the joint relationships between brain function, task
performance and structural disease load, we have identiﬁed regions in
which increased brain activity (or connectivity) in those closer to
onset is associated with preserved performance. We contend that rela-
tively preserved performance is an additional necessary component fordemonstrations of neuronal compensation. This is a new study of
neurodegenerative disease that has explicitly characterized and mea-
sured neural compensation using fMRI in combination with structural
measures of disease load and markers of task performance. Despite
the exploratory nature of our ﬁndings, they may have mechanistic im-
plications for the future planned testing of potential disease modifying
agents in the presymptomatic phases of neurodegenerative diseases
such as HD, where it may be important to monitor for preservation of
compensatory activity and connectivity.
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